Amorza 0.25% Cream
By Amorza
30gm Cream in a Tube

Composition
Amorolfine(0.25% w/w)

Manufacturer - HBC Dermiza Healthcare Pvt Ltd
Mayur House Plot No. B-218 GIDC Sec-25 Gandhi Nagar 382025 Gujarat

Expires on or after
August, 2025

liver
In relation to liver issues, there is no interaction that has been found or established regarding the use of Amorza 0.25% Cream. It is important to be cautious about any potential effects on the liver. Before using Amorza 0.25% Cream, consulting with your doctor for proper guidance is recommended to ensure your safety.

kidney
No interaction with the kidney has been found or established regarding Amorza 0.25% Cream. Consult with your doctor for proper guidance before using Amorza 0.25% Cream.

alcohol
Currently, there is no information available regarding any interactions between alcohol and Amorza 0.25% Cream. It is always important to consult with a healthcare provider if you have any concerns or questions about consuming alcohol while using Amorza 0.25% Cream.

driving
No interaction found or established with Amorza 0.25% Cream and driving. It is safe to drive while using Amorza 0.25% Cream.

pregnancy
Information regarding the safety of using Amorza 0.25% Cream during pregnancy is currently not available. It is recommended to consult with your healthcare provider before using this product.

breastfeeding
When using Amorza 0.25% Cream, caution is advised during breastfeeding. It is recommended to pause breastfeeding until the mother's treatment is finished and the drug is no longer present in her system.
Habit Forming | No |
Chemical Class | Phenylpropane Derivative |
Therapeutic Class | DERMA |
Action Class | Antifungal Others |
₹290
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024